| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/18/1989 | EP0299108A1 DNA-molecules coding for FMDH control regions and structured gene for a protein having FMDH-activity and their uses |
| 01/18/1989 | EP0299053A1 Des-epidermal growth factor plasminogen activators |
| 01/18/1989 | CN1030443A Multivalent meningococcal class 1 outer-membrane protein vaccine |
| 01/18/1989 | CN1030442A Plant tissue transformation |
| 01/17/1989 | US4798807 Monoclonal antibodies and method for detecting dioxins and dibenzofurans |
| 01/17/1989 | US4798797 Retrovirus associated with lymphadenopathies and adapted to continuous lines of lymphoblastoid B cells, capable of producing retrovirus continuously and process for their production |
| 01/17/1989 | US4798796 Cell lines and their use for the production plasminogen activators |
| 01/17/1989 | US4798791 Vector for high level gene expression |
| 01/17/1989 | US4798790 Monoclonal antibody specific for a pigmentation associated antigen |
| 01/17/1989 | US4798789 Plasmid vectors |
| 01/17/1989 | CA1248895A1 Nucleic acid reagents, a method for their preparation and their use |
| 01/17/1989 | CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods |
| 01/12/1989 | WO1989000202A2 Method for producing novel polyester biopolymers |
| 01/12/1989 | WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion |
| 01/12/1989 | WO1989000198A1 Recombinant fibroblast growth factors |
| 01/12/1989 | WO1989000197A1 Improved processes for the treatment of vascular disease |
| 01/12/1989 | WO1989000196A1 Virus proteins having reduced o-linked glycosylation |
| 01/12/1989 | WO1989000194A1 Inhibition of eucaryotic pathogens and neoplasms and stimulation of fibroblasts and lymphocytes with lytic peptides |
| 01/12/1989 | WO1989000193A1 Haloarylnitrile degrading gene, its use, and cells containing the gene |
| 01/12/1989 | WO1989000192A1 Production of kallikrein |
| 01/12/1989 | WO1989000191A1 Novel thrombolytic proteins |
| 01/12/1989 | WO1989000190A1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein |
| 01/12/1989 | WO1989000169A1 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils |
| 01/12/1989 | WO1989000163A1 Vaccines against animal parasitic nematodes |
| 01/12/1989 | WO1989000051A1 Fibrin-binding compound and method |
| 01/12/1989 | WO1989000050A1 Antigen recognized by mca 16-88 |
| 01/12/1989 | WO1989000048A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/12/1989 | WO1988009818A3 Growth hormone receptor |
| 01/12/1989 | WO1988009809A3 Cell system for expression of recombinant protein without production of virus |
| 01/12/1989 | DE3717695A1 Human manganese superoxide dismutase (hMn-SOD) |
| 01/11/1989 | EP0298918A2 Inducible virus resistance in plants |
| 01/11/1989 | EP0298807A1 Method for the production of stable cell lines from transgenic animals for the production of specific proteins; tumour cell lines and proteins obtained |
| 01/11/1989 | EP0298723A1 Recombinant fibroblast growth factors |
| 01/11/1989 | EP0298669A1 Performing nucleic acid reactions |
| 01/11/1989 | EP0298656A1 Polynucleotide probes |
| 01/11/1989 | EP0298645A2 Polypeptide possessing maltotetraose-forming amylase activity, and its uses |
| 01/11/1989 | EP0298450A2 Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions |
| 01/11/1989 | CN1030256A Methods and materials for h1v detection and therapy |
| 01/11/1989 | CN1030255A Transgenic animals |
| 01/10/1989 | US4797929 Word recognition in a speech recognition system using data reduced word templates |
| 01/10/1989 | US4797474 Solubilization of protein aggregates |
| 01/10/1989 | US4797473 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins |
| 01/10/1989 | US4797370 Antigens, bonding, immunology |
| 01/10/1989 | US4797368 Plasmids, dna, packages |
| 01/10/1989 | US4797359 Genetic engineering, dna |
| 01/10/1989 | US4797356 Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays |
| 01/10/1989 | US4797279 Insecticidal hybrid bacteria from b.t. kurstaki and b.t. tenebrionis |
| 01/10/1989 | CA1248473A1 Selectable markers for yeast transformation |
| 01/10/1989 | CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen |
| 01/05/1989 | DE3720911A1 Highly purified informational ribonucleic acid (i-RNA), preparation process and use |
| 01/04/1989 | EP0297930A2 Monoclonal antibodies |
| 01/04/1989 | EP0297924A2 Recombinant vaccinia virus expressing HSV 1 gB |
| 01/04/1989 | EP0297913A2 Production of Kallikrein |
| 01/04/1989 | EP0297882A2 Hybrid plasminogen activators |
| 01/04/1989 | EP0297833A2 Physiologically active lymphotoxin |
| 01/04/1989 | EP0297807A1 Novel prokaryotic expression and secretion system |
| 01/04/1989 | EP0297619A2 Process for the preparation of L-phenyl alanine from benzylidene hydantoin |
| 01/04/1989 | EP0297618A2 Phosphinothricin-resistant gene and its use |
| 01/04/1989 | EP0297585A2 Neuronal polypeptide and methods of production and use thereof |
| 01/04/1989 | EP0297379A2 Method for amplifying genes |
| 01/04/1989 | EP0297362A2 Human aprotinine whose Lys residue in position 15 is substituted by another protogene redisue of amino-acid |
| 01/04/1989 | EP0297291A2 Outer membrane protein F of Pseudomonas aeruginosa |
| 01/04/1989 | EP0297110A1 Polypeptides providing protective immunity against malaria |
| 01/04/1989 | EP0124561B1 Process for producing oligonucleoside phosphonates |
| 01/04/1989 | CN1030093A Production of peptide |
| 01/04/1989 | CN1030018A Avirulent microbes and uses therefor |
| 01/03/1989 | US4795855 Using dna, then regeneration |
| 01/03/1989 | US4795805 Derivative of adult T cell leukemia virus antigen peptide |
| 01/03/1989 | US4795804 Polypeptide |
| 01/03/1989 | US4795803 Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
| 01/03/1989 | US4795706 Novel expression control sequences |
| 01/03/1989 | CA1248045A1 Device and process for inducing membrane fusion under an electric field |
| 12/29/1988 | WO1988010315A1 Transcription-based nucleic acid amplification/detection systems |
| 12/29/1988 | WO1988010314A1 Detection of lymphocyte amplification |
| 12/29/1988 | WO1988010311A1 Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 12/29/1988 | WO1988010310A1 Bovine granulocyte-macrophage colony stimulating factor |
| 12/29/1988 | WO1988010308A1 Pheromone-inducible yeast promoter |
| 12/29/1988 | WO1988010307A1 Balanced constitutive inducible transcription system |
| 12/29/1988 | WO1988010306A1 Cloned protein g variant genes and the protein g variants expressed therefrom |
| 12/29/1988 | WO1988010305A1 New toxin-encoding dna fragments from bacillus thuringiensis subsp. israelensis |
| 12/29/1988 | WO1988010304A1 Dietary and hormonal regulation of expression of exogenous genes in transgenic animals under control of the promoter of the gene for phosphoenolpyruvate carboxykinase |
| 12/29/1988 | WO1988010303A1 Preparation of novel protein sweeteners |
| 12/29/1988 | WO1988010302A1 Novel plasmid, microbial cells, process for preparing polypeptide with oncostatic activity, and secreted polypeptide with oncostatic activity |
| 12/29/1988 | WO1988010300A1 Heterologous viral peptide particle immunogens |
| 12/29/1988 | WO1988010299A1 A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation |
| 12/29/1988 | WO1988010298A1 Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies |
| 12/29/1988 | WO1988010297A1 Cloning of mite allergens |
| 12/29/1988 | WO1988010295A1 MODIFIED FACTOR VII/VIIa |
| 12/29/1988 | WO1988010271A1 Preparation of novel protein sweeteners |
| 12/29/1988 | WO1988010270A1 Urinary follicle stimulating hormone |
| 12/29/1988 | WO1988010269A1 Growth factors |
| 12/29/1988 | WO1988010265A1 A new class of low calorie protein sweeteners |
| 12/29/1988 | WO1988010118A1 Expression of proteins in milk |
| 12/28/1988 | EP0297066A1 Novel fibrinolytic enzymes |
| 12/28/1988 | EP0296870A1 New toxin-encoding DNA fragments from Bacillus thuringiensis subsp.israelensis |
| 12/28/1988 | EP0296786A1 T-cell receptor gene located within alpha locus and dna constructions |
| 12/28/1988 | EP0296484A2 Promoters for the expression of foreign DNA in methylotropic bacteria, their production and use |
| 12/28/1988 | EP0296413A2 Hybrid protein C and method for its preparation |
| 12/28/1988 | EP0296222A1 A method of modifiying the metabolism of eukaryotic cells upon incorporation therein of foreign sequences of nucleic acids by means of an internalizing vector |
| 12/28/1988 | CA1247540A Intact gene and method of excising and cloning same |